Lv1
36 积分 2024-10-07 加入
CD46 Is Amplified in High-Risk Myeloma with Gain of Chromosome 1q and Selectively Targeted By a Novel Anti-CD46 Antibody-Drug Conjugate
4天前
求助中
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
4天前
已完结
Complement Receptor 3 Forms a Compact High-Affinity Complex with iC3b
1个月前
已完结
Complement Receptor 3 Forms a Compact High-Affinity Complex with iC3b
1个月前
已关闭
Structure-Guided Design of Proteomimetics Targeting the SARS-CoV-2 S-RBD/hACE2 Interface
1个月前
已完结
Discovery of Highly Selective AKR1C3 Inhibitors to Overcome EGFR C797S-Mediated Osimertinib Resistance in Non-Small Cell Lung Cancer
1个月前
已完结
Design of miniprotein inhibitors targeting complement C9 to block membrane attack complex assembly
3个月前
已完结
Complementing Anticancer Therapy: Antibody-Drug Conjugates Targeting CD46 as Prostate Cancer Treatment
7个月前
已关闭
De novo design of light-responsive protein–protein interactions enables reversible formation of protein assemblies
8个月前
已完结
皖公网安备34019202002308
